William Woods

Thomas J. White, Ph.D. has more than 30 years of experience in medical biotechnology, evenly divided among three Bay Area firms: Cetus, the pioneering biotech firm where Dr. White supervised the development of the Polymerase Chain Reaction (PCR); Roche Molecular Systems, which acquired the rights to PCR from Cetus and where the R&D group developed molecular diagnostics for HIV and other infectious diseases; and Celera, where, as Chief Scientific Officer, the discovery research group used genomic medicine to identify genes associated with chronic, complex diseases.

Return to CNRAA Board Member Profiles